Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
(NASDAQ: CRVS) Delayed: 12.56 --0 (-0%)
Previous Close $12.56    52 Week High $17.77 
Open $12.56    52 Week Low $9.63 
Day High $12.56    P/E N/A 
Day Low $12.56    EPS $0.00 
Volume 6,674